We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 1.39% | 2.19 | 2.10 | 2.19 | 2.19 | 2.11 | 2.11 | 1,127,511 | 12:05:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.92 | 7.3M |
TIDMIMM
Immupharma PLC
15 February 2018
15 February 2018
ImmuPharma PLC
("ImmuPharma" or the "Company")
London Investor Evening
Monday 26 February 2018 @ 6pm
ImmuPharma PLC (LSE: IMM), specialist drug discovery and development company, is pleased to announce that Tim McCarthy, Chairman, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as agent in the recent GBP10 million fundraise by ImmuPharma.
The event will be held on Monday 26(th) February 2018 in London, EC2 and will commence at 6pm. Further details on the event will be provided upon registration. To Register your interest, please email lisa.baderoon@immupharma.com and info@turnerpope.com or call 0203 621 4120.
-Ends-
For further information please contact: + 44 (0) 20 ImmuPharma plc (www.immupharma.org) 7152 4080 Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations lisa.baderoon@immupharma.com + 44 (0) 7721 Twitter: @immupharma 413496 Northland Capital Partners Limited (NOMAD & Broker) David Hignell, Jamie Spotswood, Corporate Finance +44 (0)20 3861 Rob Rees, Corporate Broking 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAMMGMZKDLGRZM
(END) Dow Jones Newswires
February 15, 2018 02:01 ET (07:01 GMT)
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions